John A Hartley Selected Research

Autoimmune Diseases (Autoimmune Disease)

10/2017

The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John A Hartley Research Topics

Disease

62	Neoplasms (Cancer) 02/2024 - 07/2003
7	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2004
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 06/2015
5	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 04/2011
5	Leukemia 01/2018 - 06/2003
4	Lymphoma (Lymphomas) 02/2024 - 11/2016
4	Melanoma (Melanoma, Malignant) 08/2015 - 09/2004
4	Breast Neoplasms (Breast Cancer) 12/2013 - 09/2004
3	Adenocarcinoma 02/2024 - 12/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 10/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 04/2006
2	Hypoxia (Hypoxemia) 02/2018 - 11/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 08/2005
2	Glioma (Gliomas) 07/2014 - 09/2004
2	Multiple Myeloma 09/2012 - 07/2002
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Residual Neoplasm 10/2021
1	Cytokine Release Syndrome 10/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Liver Neoplasms (Liver Cancer) 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2016
1	Circulating Neoplastic Cells 01/2016
1	Disease Progression 01/2016

Drug/Important Bio-Agent (IBA)

32	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 07/2002
12	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 11/2015
9	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 07/2023 - 11/2016
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2004
5	ProdrugsIBA 10/2019 - 11/2004
5	ErbB Receptors (EGF Receptor)IBA 06/2016 - 10/2004
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2015
4	1,1'- ((propane- 1,3- diyl)dioxy)bis(7- methoxy- 2- methylidene- 1,2,3,10,11,11a- hexahydro- 5H- pyrrolo(2,1- c)(1,4)benzodiazepin- 5,11- dione)IBA 06/2011 - 09/2004
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 04/2015
3	Proteins (Proteins, Gene)FDA Link 03/2015 - 09/2004
3	Gefitinib (Iressa)FDA Link 12/2013 - 10/2004
3	Melphalan (Alkeran)FDA LinkGeneric 09/2012 - 07/2002
3	Etoposide (VP 16)FDA LinkGeneric 11/2009 - 10/2004
2	Peptides (Polypeptides)IBA 02/2024 - 01/2020
2	Cytotoxins (Cytolysins)IBA 02/2024 - 11/2004
2	loncastuximab tesirineIBA 01/2023 - 01/2018
2	olaparibIBA 01/2022 - 02/2018
2	vandetanib (ZD6474)IBA 01/2022 - 10/2019
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2021 - 03/2015
2	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 02/2018 - 12/2015
2	A-factor (Streptomyces)IBA 10/2017 - 07/2010
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 11/2009
2	Gemcitabine FDA Link 12/2015 - 10/2010
2	PoisonsIBA 12/2013 - 09/2004
2	PlatinumIBA 09/2012 - 10/2010
2	Drug CombinationsIBA 06/2011 - 07/2010
2	Nylons (Nylon)IBA 05/2010 - 01/2007
2	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2007 - 11/2004
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 02/2024
1	IminesIBA 01/2023
1	AZD 8931IBA 01/2023
1	monomethyl auristatin EIBA 01/2022
1	auristatinIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 11/2021
1	ParaffinIBA 11/2021
1	Chimeric Antigen ReceptorsIBA 10/2021
1	SteroidsIBA 10/2021
1	LigandsIBA 09/2021
1	futuximabIBA 01/2020
1	Cell Surface ReceptorsIBA 01/2020
1	IntegrinsIBA 01/2020
1	GlucuronidaseIBA 10/2019
1	Histones (Histone)IBA 10/2018
1	glutamate carboxypeptidaseIBA 10/2018
1	MEDI3726IBA 10/2018
1	AntigensIBA 10/2018
1	Adenosine Diphosphate (ADP)IBA 02/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2018
1	TH 302IBA 02/2018
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 02/2018
1	CD19 AntigensIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Tubulin ModulatorsIBA 01/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018
1	Interleukin-2 (IL2)IBA 10/2017
1	ChromatinIBA 01/2017
1	rovalpituzumab tesirineIBA 11/2016
1	Cetuximab (Erbitux)FDA Link 06/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2016
1	ElementsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2015
1	NucleosidesIBA 12/2015
1	Caspase 3 (Caspase-3)IBA 12/2015

Therapy/Procedure

21	Therapeutics 02/2024 - 10/2004
8	Drug Therapy (Chemotherapy) 01/2023 - 09/2004
2	Stem Cell Transplantation 10/2021 - 07/2002
1	Aftercare (After-Treatment) 01/2022
1	Castration 10/2018
1	Immunotherapy 10/2017
1	Adjuvant Chemotherapy 01/2017